MD Anderson’s sarcoma team has received a $1.8M SPORE grant from the NCI to advance new immunologic and targeted sarcoma treatments. The work includes a trial of adoptive cellular therapy for chordoma and a trial of antibody-drug conjugates for osteosarcoma. #OncSky #EndCancer

Breaking news: The White House budget office on Wednesday rescinded an order freezing federal grants, according to a copy of a new memo obtained by The Post, after the administration’s move to halt spending earlier this week provoked a backlash.

Happy Holidays!

Relevant to many here — As of Dec 10, NCI is discontinuing the F32 and encouraging postdocs to apply for a K32 ACE award instead. grants.nih.gov/grants/guide... grants.nih.gov/grants/guide...

Happy Evolution Day to those who celebrate.

Great to connect with so many in my fields! The grass is greener (and sky bluer) on the other side. I’m a postdoc at MD Anderson Cancer Center in Houston, TX. I study tumor evolution, genetic instability, phenotype plasticity, and their translational applications. Great to see you all!